Results 221 to 230 of about 35,054 (306)

The impact of ceftazidime-avibactam on 30-day mortality in the treatment of OXA-48 producing <i>Enterobacterales</i> infections: a systematic review and meta-analysis. [PDF]

JAC Antimicrob Resist
Foo AL, Young B, Ng OT, Vasoo S.
europepmc   +1 more source

In vitro activity of aztreonam-avibactam and comparators against Metallo-β-Lactamase-producing Enterobacterales from ATLAS Global Surveillance Program, 2016-2020 [PDF]

Rossolini, Gian Maria
core   +1 more source

Microbiological, Clinical, and Pharmacokinetic/Pharmacodynamic Data to Support EUCAST Aztreonam-Avibactam Minimum Inhibitory Concentration Susceptibility Breakpoints Against Enterobacterales. [PDF]

Infect Dis Ther
Raber SR, Xie R, Rogers H, Soto E, Arhin FF, Stone GG, Leister-Tebbe H, Chow JW.   +7 more
europepmc   +1 more source

Maternal Colonization, Perinatal Exposure, and Neonatal Acquisition of Resistant Enterobacterales. [PDF]

Open Forum Infect Dis
Mithal LB, Sajwani A, Aron A, Shuai W, Kremer A, Watson AD, Sumner JT, Manzano VCC, Donnelly G, Miller ES, Fisher JB, Hartmann EM, Arshad M.   +12 more
europepmc   +1 more source

Role of the gut microbiome in frequent gut colonization with extended-spectrum β lactamase-producing Enterobacterales among Peruvian children

Maya Nadimpalli, Neha Sehgal, Luismarcelo Rojas-Salvatierra, Robert H. Gilman, Ashlee M. Earl, Colin J. Worby, Marjorie Schwab, Amy J. Pickering, Mónica J. Pajuelo   +8 more
openalex   +2 more sources